共 8 条
Psychiatric symptomatology in skin-restricted lupus patients without axis I psychiatric disorders: A post-hoc analysis
被引:0
|作者:
Rondepierre, Fabien
[1
]
Tauveron-Jalenques, Urbain
[2
]
Valette, Solene
[2
]
Mulliez, Aurelien
[3
]
D'Incan, Michel
[4
]
Lauron, Sophie
[2
]
Jalenques, Isabelle
[2
]
机构:
[1] CHU Clermont Ferrand, Serv Psychiat Adulte & Psychol Med, Clermont Ferrand, France
[2] Clermont Auvergne Univ, CHU Clermont Ferrand, CNRS, Inst Pascal,Serv Psychiat Adulte & Psychol Med,Cle, Clermont Ferrand, France
[3] CHU Clermont Ferrand, Direct Rech Clin & Innovat, Clermont Ferrand, France
[4] Clermont Auvergne Univ, CHU Clermont Ferrand, INSERM, Inst Pascal,Serv Dermatol,Clermont Auvergne INP, Clermont Ferrand, France
来源:
PLOS ONE
|
2023年
/
18卷
/
03期
关键词:
INTERFERON-ALPHA THERAPY;
TUMOR-NECROSIS-FACTOR;
PERSONALITY-DISORDERS;
DEPRESSIVE SYMPTOMS;
HIGH PREVALENCE;
SEX-DIFFERENCES;
IMMUNE-SYSTEM;
ANXIETY;
ERYTHEMATOSUS;
INFLAMMATION;
D O I:
10.1371/journal.pone.0282079
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
BackgroundSkin-restricted lupus is a chronic inflammatory disease associated with high rates of depression and anxiety disorders. Patients without psychiatric disorders can experience anxiety and depressive symptoms at a subclinical level, which could be risk factors for progression towards psychiatric disorders. It was decided, therefore, to investigate the presence of specific symptoms in skin-restricted lupus patients without axis I psychiatric disorders and their impact on the occurrence of axis I psychiatric disorders during the study follow-up. MethodsLongitudinal data of 38 patients and 76 matched controls without active axis I psychiatric disorders from the LuPsy cohort were used. Depressive, neurovegetative, psychic and somatic anxiety symptom scores were established from the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating scale (HAMA). ResultsNone of the participants had any current active axis I psychiatric disorders but the patients had personality disorders more frequently and had received more past psychotropic treatments than the controls. They also had higher MADRS and HAMA scores than the controls, in particular neurovegetative, psychic anxiety and somatic symptoms scores. No dermatological factor tested was associated with these scores, whereas being a lupus patient was associated with higher neurovegetative and somatic symptoms scores, having a current personality disorder with higher depressive and neurovegetative scores and receiving more past psychotropic treatments with psychic anxiety and somatic symptoms scores. The occurrence of psychiatric disorders during the study follow-up was associated with an elevated psychic anxiety score at baseline and past psychotropic treatment but not with history of psychiatric disorder. LimitationsThe LuPsy cohort included a large number of patients with axis I psychiatric disorders, the sample without axis I psychiatric disorders is therefore limited. ConclusionsWe observed numerous psychiatric symptoms among the skin-restricted lupus patients. They should therefore receive special attention in the management of their subclinical symptoms before they progress towards full psychiatric disorders.
引用
收藏
页数:16
相关论文